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Abstract
Background—Congenital heart defects (CHDs) are common birth defects and are associated 
with high hospital costs. The objectives of this study were to assess hospitalization costs, across 
the lifespan, of patients with CHDs in Arkansas.
Methods—Data from the 2006 to 2011 Healthcare Cost and Utilization Project Arkansas State 
Inpatient Databases were used. We included hospitalizations of patients whose admission occurred 
between January 1, 2006, and December 31, 2011, and included a principal or secondary CHD 
ICD-9-CM diagnosis code (745.0–747.49, except 747.0 and 745.5 for preterm infants). 
Hospitalizations were excluded if they involved out-of-state residents, normal newborn births, or 
if missing data included age at admission, state of residence, or hospital charges. Children were 
defined as those < 18 years-old at time of admission.
Results—Between 2006 and 2011, there were 2,242,484 inpatient hospitalizations in Arkansas. 
There were 9071 (0.4%) hospitalizations with a CHD, including 5,158 hospitalizations of children 
(2.2% of hospitalizations among children) and 3,913 hospitalizations of adults (0.2% of 
hospitalizations of adults). Hospital costs for these CHD hospitalizations totaled $355,543,696. 
The average annual cost of CHD hospitalizations in Arkansas was $59,257,283 during this time 
period. Infants accounted for 72% of all CHD-related hospital costs; total costs of CHD 
hospitalizations for children were almost five times those of hospitalization costs for adults with 
CHD.
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Conclusion—Hospitalizations with CHDs account for a disproportionate share of hospital costs 
in Arkansas. Hospitalizations of children with CHD accounted for a higher proportion of total 
hospitalizations than did hospitalizations of adults with CHD.
Keywords
arkansas; congenital heart defects; hospital costs; state inpatient database; healthcare cost and 
utilization project
Introduction
Congenital heart defects (CHDs) are estimated to occur in 8 to 9 per 1000 live births, 
making them one of the most common birth defects (Botto et al., 2001; Reller et al., 2008). 
With improvements in detection and treatment, most infants are surviving into adulthood 
(Khairy et al., 2010; Oster et al., 2013a), leading to a growing population of adolescents and 
adults with CHDs (Marelli et al., 2007, 2014; O’Leary et al., 2013; Opotowsky et al., 2009). 
CHDs are associated with increased hospital costs in infancy; moreover, they are associated 
with lifelong morbidity and the need for ongoing medical care. In a nationally representative 
sample from 2004, 33.5% of all newborn hospitalizations for birth defects were principally 
due to cardiac and circulatory anomalies (Russo and Elixhauser, 2007). Among 
hospitalizations of neonates with birth defects, over half of those with the highest hospital 
charges were for a CHD (CDC, 2007). High hospital costs are not limited to infancy. In a 
recent analysis of hospitalizations of individuals up to 20 years old, hospitalizations 
including a CHD as a principal or secondary diagnosis accounted for 15.1% of total 
pediatric hospital costs (Simeone et al., 2014).
While U.S.-level cost estimates are important to understanding the nationwide impact of 
CHDs, individual states differ in their management and resource allocation for CHD care. 
Information on the state-specific contribution of CHD hospitalizations to total hospital costs 
will facilitate planning for state-wide needs. The State Inpatient Databases (SID) of the 
Healthcare Cost and Utilization Project (HCUP) allow state-specific estimates of hospital 
costs to be developed (AHRQ, 2013c). This might be particularly important for estimates of 
adults with CHD using hospital resources, as surveillance of CHDs does not often extend 
beyond infancy (Oster et al., 2013b).
Each state is unique in its population of infants, children, and adults with CHD and how and 
where healthcare is delivered to these individuals. Arkansas is a state with an active, 
population-based birth defects surveillance system (NBDPN, 2014), high infant mortality 
(Matthews and MacDorman, 2013), and a large children’s hospital delivering care to infants 
and adults with CHD (Arkansas Children’s Hospital, 2013a,2013b). The objectives of this 
study were to assess costs associated with statewide hospitalizations of individuals with 
CHDs, across the lifespan, in Arkansas from 2006 to 2011 and assess the contribution of 
costs for infant and childhood hospitalizations compared with adult hospitalizations. Using 
the Arkansas SID to estimate costs of hospitalizations of patients with CHDs could serve as 
a model to other states interested in investigating the contribution of CHD hospitalizations to 
their total hospital resource use.
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This was a cross-sectional study of acute care hospitalizations of Arkansas residents with 
CHD admitted to Arkansas facilities. Data were obtained from the Agency for Healthcare 
Research and Quality’s 2006 to 2011 Arkansas SID (AHRQ, 2013c; 2014). The SID are 
administered by the Healthcare Cost and Utilization Project (HCUP) and are a set of 
inpatient, all-payer administrative databases. Each observation represents one hospital 
admission and includes information about discharge records of hospital admissions from all 
acute care hospitals in Arkansas. Each discharge record contains basic demographic 
information, payer information, and principal and secondary International Classification of 
Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis codes. We 
hypothesized low levels of in- and out-migration from the state to obtain care for CHDs 
based on previous work (Mosley et al., 2002).
CASE DEFINITION AND STUDY VARIABLES
We included hospitalizations of patients whose admission occurred between January 1, 
2006, and December 31, 2011, and included a principal or secondary CHD ICD-9-CM 
diagnosis code (745.0–747.49). Hospitalizations were excluded if they involved out-of-state 
residents or normal newborn births, or if missing data included age at admission, state of 
residence, or hospital charges. Children were defined as those < 18 years old at the time of 
discharge. If an infant hospitalization had a diagnosis of preterm birth and the only CHD 
diagnosis was isolated patent ductus arteriosus (ICD-9-CM 747.0) or secundum atrial septal 
defect (ICD-9-CM 745.5), then the patient was not considered to have a CHD.
Variables of interest included patient race (non-Hispanic white, non-Hispanic black, and 
other race at first hospital visit), sex, age (children vs. adults) and expected primary payer 
(public [Medicare and Medicaid], private, and other [self-pay, no charge, and other payer]).
HOSPITAL COSTS
All costs are reported in 2012 U.S. dollars calculated using the Purchaser Price Index for 
Hospitals (U.S. Bureau of Labor Statistics). HCUP provides total hospital charges on each 
discharge record in the SID. Charges represent what hospitals bill for services and do not 
include physician fees. Costs represent actual expenses resulting from a hospital stay, and 
include components such as supplies and wages (AHRQ, 2013a). Because hospital costs are 
not available in HCUP, they were obtained by multiplying charges by hospital- and year-
specific cost-to-charge ratios (CCRs) provided by HCUP. The HCUP CCRs are developed 
annually using cost and charge data sent by hospitals to the Centers for Medicare and 
Medicaid Services. Two CCRs are calculated for each hospital participating in the SID: a 
hospital-specific CCR and a group-average CCR, which is a weighted average CCR for 
hospitals grouped by states, location, ownership, and bedsize (AHRQ, 2013a,2013b). If 
hospital-specific CCRs were unavailable, group-average CCRs were used. If both hospital-
specific and group-average CCRs were missing, then missing CCRs were assigned a value 
equal to the mean group-average CCRs for that year. Total costs were obtained by summing 
hospital costs for all hospitalizations; total CHD costs were obtained by summing hospital 
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costs for those hospitals that included a CHD diagnosis. Total and mean costs for all 
hospitalizations, both with a CHD and without a CHD, were estimated for all years (2006–
2011).
Results
Between 2006 and 2011, there were 2,523,296 inpatient hospitalizations in Arkansas. After 
excluding hospitalizations missing data on age at admission (n = 1200), hospital charges (n 
= 2735), residency data (n = 346), or hospitalizations involving non-Arkansas residents (n = 
121,772), and hospitalizations of normal newborn births (n = 154,759), there were 2,242,484 
inpatient hospitalizations available for analysis. Of those, 9071 (0.4%) included a CHD 
diagnosis code. The total cost of all hospitalizations in Arkansas between 2006 and 2011 
was $19,168,320,183; on average, total annual cost for hospitalizations without CHDs was 
$3,135,462,748 (standard error [SE]: 36,725,366). The total cost of all hospitalizations 
including a CHD between 2006 and 2011 was $355,543,696 (1.9% of total hospital costs 
between 2006 and 2011) (Table 1); total annual cost of hospitalizations with a CHD 
averaged $59,257,283 (SE: 6,374,345). A CHD was the principal diagnosis in 1443 
hospitalizations with CHD (15.9%); however, children less than 18 years of age were more 
likely to have a CHD as their principal diagnosis (n = 972, 18.8% of children with CHD) 
compared with adults over 18 years of age (n = 471, 12.0% of adults with CHD, p < 0.001).
Hospitalizations of children accounted for 57% of all hospitalizations with a CHD and 
accumulated $292,432,282 in hospital costs, 82% of all CHD costs (Table 1). In contrast, 
hospitalizations of children accounted for only 10.1% of non-CHD admissions and these 
hospitalizations accumulated $1,709,930,181 in hospital costs, 9% of all non-CHD costs. 
The majority of hospital costs among those with CHD were incurred for admissions of 
individuals < 1 year of age (72% of total costs). Among hospitalizations without a CHD, 
individuals over 64 years of age incurred 45% of total costs.
Hospitalizations of patients with and without a CHD differed by several demographic 
characteristics. Hospitalizations of those who were < 1 year of age accounted for 46.5% of 
hospitalizations that included a CHD, but 4.6% of hospitalizations without a CHD (Table 2). 
While the proportion of male and female hospitalizations among those with CHD was 
approximately equal (49.7% and 50.3%, respectively), among hospitalizations without a 
CHD, women accounted for 60.2% of hospitalizations. By race, hospitalizations of non-
Hispanic white patients represented a slightly smaller proportion of CHD hospitalizations 
compared with non-CHD hospitalizations; hospitalizations of other-race individuals 
represented a slightly higher proportion of CHD hospitalizations compared with non-CHD 
hospitalizations. Overall, a slightly higher percentage of hospitalizations without a CHD had 
an expected public payer (64.8%) compared with hospitalizations with a CHD (60.3%); 
however, expected payer varied substantially by age at admission. Among hospitalizations 
with a CHD, 57.6% of patients with an expected public payer were < 1 year of age; among 
hospitalizations without a CHD, 4.5% of patients with an expected public payer were < 1 
year of age.
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Overall, hospitalizations with a CHD had higher mean and median hospitalization costs than 
hospitalizations without a CHD (mean costs: $39,196 and $8423, respectively; Median 
costs: $11,133 and $5034, respectively) (Table 2). Mean and median per-hospital costs were 
higher for hospitalizations with a CHD at all levels of age, gender, race, and payer. Within 
levels of expected payer, hospital costs of hospitalizations with a CHD varied widely by age 
at admission. Among CHD hospitalizations with a public payer, hospital costs averaged 
$42,053, with a median of $11,436; however, these mean hospital costs ranged from 
$12,166 per hospitalization among patients 18 to 45 years of age to $66,074 per 
hospitalization for patients < 1year of age. Mean and median hospital costs varied by 
hospital experience. Admission type, presence of an injury, experiencing an invasive 
surgical procedure, and length of stay impacted hospital costs among hospitalizations with 
and without a CHD (Supplementary Table S1, which is available online).
Discussion
This analysis of population-based hospital discharge data from patients with CHD reveals 
variations in hospital costs by patient demographic characteristics. Hospitalizations with 
CHD accounted for approximately 2% of the total inpatient hospital costs in Arkansas; 
average hospital cost was significantly higher for hospitalizations with a CHD compared 
with hospitalizations without a CHD. Among hospitalizations with a CHD, the majority of 
costs were accrued by hospitalizations of children, with nearly three-fourths of hospital costs 
originating from those < 1 year of age. Moreover, hospitalizations of patients with CHD and 
an expected public payer were most costly on average than other hospitalizations. While not 
representative of national hospital costs for CHDs, these costs provide insight into Arkansas-
specific costs for the hospitalizations of patients CHD and this analytic approach can be a 
model for use in other states.
Our findings are consistent with literature demonstrating high costs for hospitalizations with 
CHDs among infants and children. Lu et al. (2014), noted that during the transition from 
childhood to young adulthood, total annual costs among hospital admissions with a CHD 
decreased as a percent of all-patient costs. Similarly, total Arkansas 2006 to 2011 costs 
decreased relative to total costs as age at admission increased. Other studies have 
demonstrated higher mean costs for CHD hospitalizations occurring in childhood compared 
with adulthood. In a recent analysis of national data using the Kids’ Inpatient Database, 
hospitalizations of those < 1 year had higher mean costs than hospitalizations of other 
pediatric patients (Simeone et al., 2014). Additionally, as evidenced by our findings, 
differences in payer type have been found to be associated with hospital costs (Connor et al., 
2005; Simeone et al., 2014; Bhatt et al., 2015). Generally, CHD hospitalizations with an 
expected public payer have been associated with increased costs. We also observed that 
mean costs of hospitalizations with CHD decrease among all payer types as age at admission 
increases.
Hospitalizations of adults with a CHD diagnosis accounted for 40% of the Arkansas 
inpatient population with CHD. In the United States, the population of adults with CHD is 
increasing as a result of improved diagnosis, advancements in medical and surgical care, and 
resultant survival past infancy (Warnes et al., 2001; Oster et al., 2013a). In Canada, the 
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number of adults with CHD is now approximately double the number of children with CHD 
(Marelli et al., 2014), and the hospitalization rate of adults with CHDs is growing faster than 
that of children with CHDs. Between 2004 and 2010, 37% of U.S. hospitalizations of 
individuals with CHDs occurred in those over age 18 (O’Leary et al., 2013). Our study 
observed that adults admitted with a CHD experienced substantially higher costs than those 
admitted without a CHD. Because the adult population with CHD is growing, understanding 
factors associated with hospital costs is becoming more important.
Our study was subject to several limitations. First, the SID are a collection of multiple 
administrative datasets. We used ICD-9-CM codes to identify any hospitalization in which a 
CHD diagnosis was ever coded. Lack of clinically verified diagnosis codes are a known 
weakness of administrative data and CHDs are prone to misclassification (Frohnert et al., 
2005; Strickland et al., 2008). In a recent analysis of the Pediatric Health Information 
Systems database (an administrative database) and the Society of Thoracic Surgeons 
Congenital Heart Surgery Database (a clinical registry), differential case ascertainment of 
children with CHDs undergoing surgical procedures existed (Pasquali et al., 2013). In 
situations in which a surgical procedure does not occur, there may be also systematic 
differences impacting when a CHD ICD-9-CM code is recorded. Misclassification of 
hospitalizations with or without CHDs, particularly in hospitalizations of older patients, 
could inflate or deflate estimates of costs. Additionally, some CHDs may be more likely to 
be coded than others, leading to over-representation and under-representation of CHDs of 
varying severity. Second, inclusion and exclusion criteria were developed to be inclusive; 
hospitalizations were included if their hospital discharges included a diagnosis of any CHD. 
For example, secundum atrial septal defect (ICD-9-CM 745.5) was diagnosed in 34.2% of 
all CHD hospitalizations (data not shown); it was the only CHD ICD-9-CM code in 21.6% 
of CHD hospitalizations. While we excluded preterm births with only this code, presence of 
this diagnosis code alone among patients without a preterm birth code might have inflated 
our estimates of hospital costs.
Third, there are known issues with estimates of hospital costs. The costs presented did not 
include physician fees, which increase the total cost of hospitalizations (Rogowski, 1998). 
Nursing wages, which are incorporated into HCUP charges, are lower in Arkansas compared 
with the U.S. population (U.S. Bureau of Labor Statistics, 2014). Therefore, all cost 
estimates are specific to CHDs treated in Arkansas hospitals and cannot be extrapolated to 
represent U.S. costs or costs for CHDs treated in an outpatient setting. In addition, this 
analysis only considers costs to hospitals treating Arkansas residents; costs to Arkansas 
hospitals for treatment of CHDs of nonresidents traveling to specialized treatment centers 
are not considered. Hospitalizations of Arkansas residents occurring out of state are also not 
considered, which may underestimate the true burden of CHD care to Arkansas. In a study 
of differences in birth defects ascertainment in three Arkansas regions, approximately 7% of 
births occurred out of state; moreover, birth defects prevalence was significantly lower in 
the northeastern region of the state, where a large hospital in Tennessee is likely providing 
care to Arkansas residents (Mosley et al., 2002).
Fourth, survival among infants born with CHD has improved significantly over time, such 
that the population of infants and children currently being treated for CHDs is likely 
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different from the population of older adults with CHDs (Warnes et al., 2001; Hoffman et 
al., 2004; Oster et al., 2013a; Wang et al., 2015). Different factors may be influencing costs 
and hospitalization experiences of the younger cohort with CHD compared with the older 
cohort with CHD, as those surviving to an older age may have less severe CHD types. 
Finally, because this analysis was conducted at the hospital level, we could not assess 
patient level factors that may contribute to hospital costs, including transfers into and out of 
the hospital. The lack of ability to examine hospital transfers may have inflated costs or 
biased mean and median estimates, particularly among infants, when transfers soon after 
birth may be more likely.
Despite these weaknesses, our study benefited from using 6 years of data to examine total 
costs of hospitalizations with CHDs. Additionally, because the SID include allpayers, we 
were able to examine all hospitalizations within Arkansas, as opposed to only 
hospitalizations specific to a single payer type.
Conclusions
In an analysis of Arkansas inpatient hospital costs, hospitalizations including a CHD were, 
on average, more expensive than other, non-CHD hospitalizations. Costs of hospitalizations 
for a CHD were highest for children. Because the population with CHDs is growing, 
hospital resources dedicated to their care are expected to increase. Using state-specific 
administrative datasets may provide insight to state-specific needs beyond national estimates 
to the costs of inpatient treatment of serious conditions such as CHDs.
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TABLE 1
Total Costs of Hospitalizations with and without a Congenital Heart Defect Diagnosis, by Age at Admission, 
Arkansas State Inpatient Database, 2006 to 2011a
Hospitalizations including a congenital heart
defect diagnosis
Hospitalizations not including a congenital heart
defect diagnosis
N % Total cost (U.S. $)b N % Total cost (U.S. $)b
All hospitalizations 9071 355,543,696 2,233,413 18,812,776,487
Age (years)
 <1 4214 46.5 254,253,464 102,112 4.6 780,125,059
 1-3 469 5.2 18,158,956 24,905 1.1 155,520,983
 4-17 475 5.2 20,019,861 98,248 4.4 774,284,139
 18-45 1161 12.8 16,467,877 584,937 26.2 3,424,832,597
 46-64 1200 13.2 21,169,246 528,099 23.7 5,242,707,765
 ≥65 1552 17.1 25,474,292 895,112 40.1 8,435,305,944
Patients < 18 years of age 5158 56.9 292,432,282 225,265 10.1 1,709,930,181
Patients ≥ 18 years of age 3913 43.1 63,111,415 2,008,148 89.9 17,102,846,306
a
Excludes hospitalizations missing age, hospital charges, and hospitalizations of out of state residents and normal newborn births
b
Costs have been adjusted to 2012 dollars using the Purchaser Price Index for Hospitals













Simeone et al. Page 11
TABLE 2
Hospital-Level Characteristics and Costs for Congenital Heart Defect and Other Hospitalizations, Arkansas 
State Inpatient Databases 2006 to 2011a
Hospitalizations including a congenital
heart defect diagnosis
Hospitalizations not including a congenital
heart defect diagnosis
N (%) Mean costb
Median costb
(25th–75th percentile) N Mean costb
Median costb
(25th–75th percentile)
All hospitalizations 9071 39,196 (1020) 11,133 (3851-36,041) 2,233,413 8423 (9) 5034 (2883-9382)
Age (years)
 <1 4214 (46.5) 60,335 (2039) 16,371 (2507-60,255) 102,112 (4.6) 7640 (94) 1438 (830-3581)
 1-3 469 (5.2) 38,718 (3291) 17,586 (3660-41,775) 24,905 (1.1) 6245 (140) 2422 (1485-4486)
 4-17 475 (5.2) 42,147 (4049) 29,084 (4672-49,142) 98,248 (4.4) 7881 (64) 3660 (2404-5966)
 18-45 1161 (12.8) 14,184 (656) 6564 (3510-15,393) 584,937 (26.2) 5855 (14) 3686 (2388-6010)
 46-64 1200 (13.2) 17,641 (302) 10,203 (5592-23,666) 528,099 (23.7) 9928 (19) 6299 (3648-11,236)
 ≥65 1552 (17.1) 16,414 (506) 9566 (5200-19,747) 895,112 (40.1) 9424 (12) 6339 (3697-11,073)
Gender
 Male 4510 (49.7) 43,382 (1503) 13,338 (4205-40,744) 888,837 (39.8) 9724 (18) 5642 (3049-10,820)
 Female 4559 (50.3) 35,071 (1377) 9636 (3578-32,113) 1,344,437 (60.2) 7564 (10) 4713 (2799-8494)
 Missing 2 (0.0) 139 (0.0)
Race
 Non-Hispanic White 6959 (76.7) 36,361 (1088) 10,699 (3910-33,950) 1,804,528 (80.8) 8508 (10) 5185 (2954-9640)
 Non-Hispanic Black 1385 (15.3) 50,972 (2896) 13,625 (4342-48,547) 343,487 (15.4) 8306 (28) 4724 (2803-8590)
 Otherc 714 (7.9) 44,431 (4820) 12,056 (2809-43,045) 83,323 (3.7) 6936 (56) 3524 (2079-6234)
 Missing 13 (0.1) 2075 (0.1)
Expected payer (overall and by age at admission)
Public 5471 (60.3) 42,056 (1490) 11,436 (3911-36,568) 1,447,051 (64.8) 8621 (12) 5215 (2983-9680)
 <1 2603 (47.6) 66,074 (2934) 18,810 (2980-63,141) 65,585 (4.5) 8032 (124) 1511 (853-3676)
 1-3 298 (5.5) 34,681 (3894) 13,889 (3170-39,635) 16,738 (1.2) 6376 (179) 2405 (1489-4394)
 4-17 285 (5.2) 41,203 (5752) 26,931 (3847-46,394) 61,271 (4.2) 73,987 (77) 3596 (2440-5516)
 18-45 462 (8.4) 12,166 (1094) 5133 (3058-12,208) 252,215 (4.2) 5594 (22) 3462 (2299-5564)
 46-64 406 (7.4) 17,246 (1085) 9790 (4822-21,243) 231,510 (17.4) 9864 (30) 6067 (3548-10,940)
 ≥65 1417 (25.9) 16,512 (536) 6339 (3716-11,034)
Private 2733 (30.1) 39,184 (1518) 12,589 (4100-39,369) 519,702 (23.3) 8235 (21) 4771 (2737-8950)
 <1 1256 (46.0) 58,253 (2972) 17,949 (2264-64,140) 25,480 (4.9) 8145 (195) 1408 (815-3799)
 1-3 138 (5.1) 45,611 (6334) 26,423 (4534-50,346) 6323 (1.2) 6217 (255) 2455 (1452-4828)
 4-17 158 (5.8) 44,677 (6266) 31,219 (8882-51,650) 27,327 (5.3) 8499 (134) 3864 (2313-6910)
 18-45 501 (18.3) 15,907 (984) 8468 (4633-18,854) 205,253 (39.5) 5912 (23) 3870 (2495-6178)
 46-64 589 (21.6) 18,688 (865) 11,063 (5928-25,373) 204,924 (39.4) 10,190 (31) 6668 (3825-11,716)
 ≥65 91 (3.3) 17,503 (2083) 10,452 (5311-21,794) 50,395 (9.7) 9903 (66) 6128 (3301-11,409)
Otherd 739 (8.2) 21,251 (1613) 6978 (2840-24,441) 239,943 (10.7) 7503 (25) 4490 (2591-8145)
 <1 275 (37.2) 26,304 (3504) 4144 (1307-28,045) 9656 (4.0) 3466 (112) 1091 (714-2271)
 1-3 33 (4.5) 46,353 (15,820) 36,341 (3155-50,883) 1645 (0.7) 5322 (423) 2396 (1533-4304)
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Hospitalizations including a congenital
heart defect diagnosis
Hospitalizations not including a congenital
heart defect diagnosis
N (%) Mean costb
Median costb
(25th–75th percentile) N Mean costb
Median costb
(25th–75th percentile)
 4-17 31 (4.2) 39,252 (6197) 37,425 (10,420-50,825) 7459 (3.1) 8724 (246) 3695 (2291-6677)
 18-45 187 (25.3) 14,660 (1483) 6697 (3682-16,629) 120,997 (50.4) 6265 (31) 3889 (2401-6592)
 46-64 186 (25.1) 14,669 (1294) 8274 (4877-18,287) 85,272 (35.5) 9377 (46) 5963 (3491-10,662)
 ≥65 27 (3.7) 9434 (1753) 6135 (4880-11,047) 14,914 (6.2) 9075 (88) 6025 (3376-11,161)
 Missing 128 (1.4) 26,717 (1.2)
a
Excludes hospitalizations missing age, hospital charges, hospitalizations of out of state residents, and normal newborn births.
b
Costs have been adjusted to 2012 U.S. dollars using the Purchaser Price Index for Hospitals.
c
Other race includes Hispanic, Asian or Pacific Islander, Native American, and other race.
d
Other payer includes self-pay, no charge, and other payer.
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